share_log

Rigel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Master Fund, L.P.(5.4%),Soleus Capital, LLC(5.4%), etc.

SEC announcement ·  Feb 2 10:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more